Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Miceli

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Bone Marrow Transplantation|December 8, 2015
Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working PartyA Necchi, R Miceli, M Bregni, et al.
ESMO Open|January 21, 2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized diseaseC Giani, G G Baldi, S Ljevar, et al.
ESMO Open|September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working GroupC Giani, R A Denu, S Ljevar, et al.
ESMO Open|June 5, 2021
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of expertsS Stacchiotti, A B Miah, A M Frezza, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Bone Marrow Transplantation|December 8, 2015
Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working PartyA Necchi, R Miceli, M Bregni, et al.
ESMO Open|January 21, 2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized diseaseC Giani, G G Baldi, S Ljevar, et al.
ESMO Open|September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working GroupC Giani, R A Denu, S Ljevar, et al.
ESMO Open|June 5, 2021
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of expertsS Stacchiotti, A B Miah, A M Frezza, et al.
Pageof 10